Lead-203 as a label for radioimaging
Abstract
A radiopharmaceutical composition comprising a radioactive isotope of lead (Pb-203) in combination with a pharmaceutical or an antibody or antibody fragment and a bifunctional chelating agent. These compositions are especially useful in the imaging and diagnosis of tumors and tumor metastases.
- Inventors:
- Issue Date:
- Research Org.:
- Brookhaven National Lab. (BNL), Upton, NY (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1176609
- Patent Number(s):
- H000735
- Application Number:
- 07/175424
- Assignee:
- The United States of America as represented by the United States Department of Energy (Washington, DC)
- DOE Contract Number:
- AC02-76CH00016
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 1988 Mar 30
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 62 RADIOLOGY AND NUCLEAR MEDICINE; 60 APPLIED LIFE SCIENCES; statutory invention registration
Citation Formats
Srivastava, Suresh C., and Meinken, George E. Lead-203 as a label for radioimaging. United States: N. p., 1990.
Web.
Srivastava, Suresh C., & Meinken, George E. Lead-203 as a label for radioimaging. United States.
Srivastava, Suresh C., and Meinken, George E. Tue .
"Lead-203 as a label for radioimaging". United States. https://www.osti.gov/servlets/purl/1176609.
@article{osti_1176609,
title = {Lead-203 as a label for radioimaging},
author = {Srivastava, Suresh C. and Meinken, George E.},
abstractNote = {A radiopharmaceutical composition comprising a radioactive isotope of lead (Pb-203) in combination with a pharmaceutical or an antibody or antibody fragment and a bifunctional chelating agent. These compositions are especially useful in the imaging and diagnosis of tumors and tumor metastases.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1990},
month = {2}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.